Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Uric Acid on the Development of Chronic Kidney Disease: The Korean Multi-Rural Communities Cohort Study

  • Mun, Kwang Ho (Department of Preventive Medicine, Keimyung University School of Medicine) ;
  • Yu, Gyeong Im (Department of Preventive Medicine, Keimyung University School of Medicine) ;
  • Choi, Bo Youl (Department of Preventive Medicine, Hanyang University College of Medicine) ;
  • Kim, Mi Kyung (Department of Preventive Medicine, Hanyang University College of Medicine) ;
  • Shin, Min-Ho (Department of Preventive Medicine, Chonnam National University Medical School) ;
  • Shin, Dong Hoon (Department of Preventive Medicine, Keimyung University School of Medicine)
  • Received : 2018.05.21
  • Accepted : 2018.08.10
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Several studies have investigated the effects of serum uric acid (SUA) levels on chronic kidney disease (CKD), with discrepant results. The effect of SUA levels on CKD development was studied in the Korean rural population. Methods: A total of 9695 participants aged ${\geq}40years$ were recruited from 3 rural communities in Korea between 2005 and 2009. Of those participants, 5577 who participated in the follow-up and did not have cerebrovascular disease, myocardial infarction, cancer, or CKD at baseline were studied. The participants, of whom 2133 were men and 3444 were women, were grouped into 5 categories according to their quintile of SUA levels. An estimated glomerular filtration rate of < $60mL/min/1.73m^2$ at the time of follow-up was considered to indicate newly developed CKD. The effects of SUA levels on CKD development after adjusting for potential confounders were assessed using Cox proportional hazard models. Results: Among the 5577 participants, 9.4 and 11.0% of men and women developed CKD. The hazard ratio (HR) of CKD was higher in the highest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.60; 95% confidence interval [CI], 1.02 to 2.51) and women (adjusted HR, 1.56; 95% CI, 1.14 to 2.15). Furthermore, CKD development was also more common in the lowest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.83; 95% CI, 1.15 to 2.90). The effect of SUA was consistent in younger, obese, and hypertensive men. Conclusions: Both high and low SUA levels were risk factors for CKD development in rural Korean men, while only high levels were a risk factor in their women counterparts.

Keywords

References

  1. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011;80(12):1258-1270. https://doi.org/10.1038/ki.2011.368
  2. Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J, et al. Lessons from 30 years' data of Korean end-stage renal disease registry, 1985-2015. Kidney Res Clin Pract 2015;34(3):132-139. https://doi.org/10.1016/j.krcp.2015.08.004
  3. Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013. J Korean Med Sci 2016;31(6):915-923. https://doi.org/10.3346/jkms.2016.31.6.915
  4. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44(4):642-650. https://doi.org/10.1016/S0272-6386(04)00934-5
  5. Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol 2005;32(5):906-912.
  6. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19(5):640-653. https://doi.org/10.1093/oxfordjournals.molbev.a004123
  7. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int 2017;37(9):1499-1506. https://doi.org/10.1007/s00296-017-3768-4
  8. Chen H, Mosley TH, Alonso A, Huang X. Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2009;169(9):1064-1069. https://doi.org/10.1093/aje/kwp033
  9. Annanmaki T, Pessala-Driver A, Hokkanen L, Murros K. Uric acid associates with cognition in Parkinson's disease. Parkinsonism Relat Disord 2008;14(7):576-578. https://doi.org/10.1016/j.parkreldis.2007.11.001
  10. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005;11(32):4145-4151. https://doi.org/10.2174/138161205774913255
  11. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116(8): 894-900. https://doi.org/10.1161/CIRCULATIONAHA.107.703389
  12. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009;61(2):225-232. https://doi.org/10.1002/art.24164
  13. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18(6):523-530. https://doi.org/10.1023/A:1024600905574
  14. Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y. Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study. BMC Nephrol 2011;12:31. https://doi.org/10.1186/1471-2369-12-31
  15. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009;53(5):796-803. https://doi.org/10.1053/j.ajkd.2008.12.021
  16. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F; MMKD Study Group. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 2008;43(4):347-352. https://doi.org/10.1016/j.exger.2008.01.006
  17. Nashar K, Fried LF. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor? Adv Chronic Kidney Dis 2012;19(6):386-391. https://doi.org/10.1053/j.ackd.2012.05.004
  18. Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 2015;65(4):543-549. https://doi.org/10.1053/j.ajkd.2014.11.016
  19. Kanda E, Muneyuki T, Kanno Y, Suwa K, Nakajima K. Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One 2015; 10(2):e0118031. https://doi.org/10.1371/journal.pone.0118031
  20. Suliman ME, Johnson RJ, Garcia-Lopez E, Qureshi AR, Molinaei H, Carrero JJ, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006;48(5):761-771. https://doi.org/10.1053/j.ajkd.2006.08.019
  21. Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P, et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 2009;29(2):79-85. https://doi.org/10.1159/000151292
  22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150(9):604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
  23. Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N, et al. Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function. PLoS One 2015;10(9):e0137449. https://doi.org/10.1371/journal.pone.0137449
  24. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283(18):2404-2410. https://doi.org/10.1001/jama.283.18.2404
  25. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007;50(2):239-247. https://doi.org/10.1053/j.ajkd.2007.05.013
  26. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005;16(7):1909-1919. https://doi.org/10.1681/ASN.2005010063
  27. Sanchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008;295(4):F1134-F1141. https://doi.org/10.1152/ajprenal.00104.2008
  28. Kim IY, Lee DW, Lee SB, Kwak IS. The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship. Biomed Res Int 2014;2014:638732.
  29. Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Nephrology (Carlton) 2011;16(8):767-776. https://doi.org/10.1111/j.1440-1797.2011.01513.x
  30. Bellomo G, Selvi A. Uric acid: the lower the better? Contrib Nephrol 2018;192:69-76.
  31. Ohta T, Sakano T, Ogawa T, Kato J, Awaya Y, Kihara H, et al. Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature. Clin Nephrol 2002; 58(4):313-316. https://doi.org/10.5414/CNP58313
  32. Kikuchi Y, Koga H, Yasutomo Y, Kawabata Y, Shimizu E, Naruse M, et al. Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction. Clin Nephrol 2000;53(6):467-472.
  33. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81(5):442-448. https://doi.org/10.1038/ki.2011.379
  34. Kand'ar R, Zakova P, Muzakova V. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. Clin Chim Acta 2006;365(1-2):249-256. https://doi.org/10.1016/j.cca.2005.09.002
  35. Nishizaki N, Fujinaga S, Hirano D, Kanai H, Kaya H, Ohtomo Y, et al. Hereditary renal hypouricemia: a cause of calcium oxalate urolithiasis in a young female. Clin Nephrol 2012;77(2): 161-163. https://doi.org/10.5414/CN106949
  36. Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, et al. The influence of serum uric acid on renal function in patients with calcium or uric acid stone: a population-based analysis. PLoS One 2017;12(7):e0182136. https://doi.org/10.1371/journal.pone.0182136
  37. Chang Y, Ryu S, Choi Y, Zhang Y, Cho J, Kwon MJ, et al. Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med 2016;164(5):305-312. https://doi.org/10.7326/M15-1323
  38. Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole SR, et al. Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod 2013;28(7):1853-1862. https://doi.org/10.1093/humrep/det085
  39. Takiue Y, Hosoyamada M, Kimura M, Saito H. The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids 2011;30(2): 113-119. https://doi.org/10.1080/15257770.2010.551645
  40. Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, et al. Defining incident chronic kidney disease in the research setting: the ARIC Study. Am J Epidemiol 2009;170(4):414-424. https://doi.org/10.1093/aje/kwp151

Cited by

  1. Threshold Effects of Serum Uric Acid on Chronic Kidney Disease in US Women without Hypertension and Diabetes: A Cross-Sectional Study vol.44, pp.5, 2019, https://doi.org/10.1159/000502183
  2. Genetically Elevated Serum Uric Acid and Renal Function in an Apparently Healthy Population vol.104, pp.3, 2020, https://doi.org/10.1159/000504267
  3. Association between Serum Uric Acid Level and ESRD or Death in a Korean Population vol.35, pp.28, 2020, https://doi.org/10.3346/jkms.2020.35.e254
  4. Renal effects of uric acid: hyperuricemia and hypouricemia vol.35, pp.6, 2018, https://doi.org/10.3904/kjim.2020.410
  5. Hyperuricemia Predicts Residual Diuresis Decline in Peritoneal Dialysis Patients vol.18, pp.1, 2018, https://doi.org/10.29333/ejgm/9297
  6. U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2 vol.44, pp.1, 2021, https://doi.org/10.1038/s41440-020-0532-z
  7. Sex-Specific Association of Uric Acid and Kidney Function Decline in Taiwan vol.11, pp.5, 2018, https://doi.org/10.3390/jpm11050415